Cost-Effectiveness Analysis Of Ceftriaxon And Chloramphenicol In Pediatric Patients With Tyfoid Fever In Hospital X, Jombang Regency
DOI:
https://doi.org/10.30994/jqph.v6i2.446Keywords:
Ceftriaxone, Chloramphenicol, Cost Effectiveness Analysiss, Typhoid FeverAbstract
Typhoid fever is a disease caused by infection by the bacterium Salmonella typhi which infects the human digestive tract. Typhoid fever is spread all over the world, it is estimated that the incidence is between 11-21 million cases per year with a death rate reaching 215,000 (Rampengan, 2016). The main treatment for typhoid fever is by administering antibiotics and also bed rest. The first antibiotic administered as therapy for typhoid fever was chloramphenicol. But along with technological developments which affect the drug development as well, many new antibiotics for typhoid fever have been discovered, such as ceftriaxone antibiotic (Rampengan, 2016). This study aims to find out a more cost-effective therapy for the treatment in pediatric patients with typhoid fever in Jombang Public Hospital. This study used a cross-sectional research design with retrospective data collection. The samples in this study were 31 pediatric patients with typhoid fever with 16 patients were administering ceftriaxone injection antibiotic therapy and 15 patients were administering chloramphenicol injection antibiotic therapy. Data were identified using the cost-effectiveness analysis of ACER and ICER calculations with the long-of-stay therapy outcome. The results showed that ceftriaxone had a lower ACER value of IDR 1,687,279.88 with an effectiveness of 100%, compared to the ACER of chloramphenicol which had value of IDR 2,336,405.29 with an effectiveness of 86.67%. From these results it was concluded that ceftriaxone is more cost-effective than chloramphenicol.
References
ACost-EffectivenessIndonesVol.02malia L, dkk. 2018. Cost-EffectivenessIndonesVol.02malia L, dkk. 2018. Cost-Effectiveness Analissys Kloramfenikol dan Seftriakson Untuk Pengobatan Demam Tifoid Pada Pasien Dewasa di Rumah Sakit Sanglah Denpasar. Media Pharmaceutica Indonesia. Vol.02 No.02.
Andayani T.M., 2013. Farmakoekonomi Prinsip dan Metodologi. Bursa ilmu. Yogyakarta.
Bhutta ZA. Khan TA, Mola AM. 1994. Therapy Of Multidrug Resistant Typhoid Fever With Oral Cefixime Vs Intravenous Ceftriaxone. Pediatric Infect Dis. 1994; 13;990-4.
Cita YP. 2011. Bakteri Salmonella typhi dana demm tifoid. Jurnal Kesehatan Masyarakat Andalas, 6(1):42-6.
Clinycal Pathway RSUD Jombang.
Cooke F, Wain j. 2004. The Emergence of antibiotic resistance in typhoid fever. Travel Med Infec Dis, 2(2):67-74.
Depkes RI. 2013. Sistematik Pedoman Pengendalian Penyakit Demam Tifoid. Jakarta: Direktorat Jendral Pengendalian Penyakit & Penyehatan lingkungan.
Eva Sartika Dasopang , Fenny Hasanah, Teddy Kurniawan Bakri, Muktia Isma. 2019. Comparative Effectiveness Study of Chloramphenicol and Ceftriaxone in the Treatment of Typhoid Fever in Children Admitted to Putri Hijau Kesdam Hospital Medan. Herbal medicline in pharmaceutical and clinical science.
Haluang, O., dkk. 2015. Analisis Biaya Penggunaan Antibiotikpada Penderita Demam Tifoid Anak Di Instalasi Rawat Inap RSUD Prof. Dr. R.D. Kandou Manado Periode Januari 2013-Juni 2014. Pharmacon, 4(3), 117-125.
Menkes. 2006. Pedoman Pengendalian Demam Tifoid. Jakarta: Kementrian Kesehatan RI ; 2006.
Nuraini, Avisha dkk. 2015. Perbandingan Kloramfenikol Dengan Seftriakson Terhadap Lama Hari Turun Demam Pada Anak Demam Tivoid . Universitas Bandung.
Nurvina W.A. 2013. Hubungan Antara Sanitasi Lingkungan, Higiene Perorangan dan Karakter Individu Dengan Kejadian Demam Tifoid di Wilayah Kerja Puskesmas Kedungmudu Kota Semarang Tahun 2012. Semarang.
Rampengan, N. H. 2016. Antibiotik Terapi Demam Tifoid Tanpa Komplikasi pada Anak. Sari Pediatri, 14(5), 271.
Siagian, Siti Erlina. 2011. Analisis Efektivtas Biaya Kloramfenikol Dan Seftriakson Pada Pengobatan Demam Tifoid Dewasa Rawat Inap Di Rumah Sakit Umum Padangsidimpuan. Universitas Sumatra Utara: Medan.
World Health Organization. 2011. Guideline for the Management of Typhoid Fever. Switzerland: World Health Organization.